
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
over 30 years ago
Participantsover 30 years ago
Defining the Patient at Risk for NSAID Toxicityover 30 years ago
GI Toxicity of NSAIDs: Incidence, Complications, Management Strategy


